Effects and mechanisms of mesenchymal stem/stromal cell functions for treatment of hematologic malignancies: promises and challenges

Myoung Woo Lee; Myoung Woo Lee; Somi Ryu; Somi Ryu; Dae Seong Kim; Dae Seong Kim; Ji Won Lee; Ji Won Lee; Ki Woong Sung; Ki Woong Sung; Hong Hoe Koo; Hong Hoe Koo; Keon Hee Yoo; Keon Hee Yoo

doi:10.18632/oncotarget.23956

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/04/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Effects and mechanisms of mesenchymal stem/stromal cell functions for treatment of hematologic malignancies: promises and challenges

Myoung Woo Lee _, Myoung Woo Lee, Somi Ryu, Somi Ryu, Dae Seong Kim, Dae Seong Kim, Ji Won Lee, Ji Won Lee, Ki Woong Sung, Ki Woong Sung, Hong Hoe Koo, Hong Hoe Koo, Keon Hee Yoo and Keon Hee Yoo _

Myoung Woo Lee1,2,*, Somi Ryu3,*, Dae Seong Kim1,2, Ji Won Lee1, Ki Woong Sung1, Hong Hoe Koo1,2,4 and Keon Hee Yoo1,2,5

1 Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

2 Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, Seoul, Korea

3 Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea

4 Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea

5 Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea

* These authors contributed equally to this work

Correspondence to:

Keon Hee Yoo, email: [email protected]

Keywords: mesenchymal stem/stromal cell; hematologic malignancy; leukemia; anti-cancer therapy; cell therapy

Received: August 29, 2017 Accepted: November 16, 2017 Epub: January 04, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23956

Publication Alerts

Withdrawal Notice

Research Papers:

Effects and mechanisms of mesenchymal stem/stromal cell functions for treatment of hematologic malignancies: promises and challenges